The elimination of drugs excreted predominantly by the kidney is slowed as renal function deteriorates. In the functionally anephric patient one would like to know how much of a drug is removed during one hemodialysis. The best estimate of this is obtained by giving the drug intravenously and measuring the amount removed in the spent dialysate (1) .
For drugs distributed according to a multicompartment pharmacokinetic model, the kinetics were first predicted theoretically (2) and then studied experimentally (3) . Hemodialysis reduced the movement (intercompartmental clearance, OS) of drug from slowly equilibrating tissue reservoirs to the central or plasma compartment. This decreased the amount of drug removed by hemodialysis compared to the predicted quantity removed had such an alteration not occurred. It was further shown (2, 3) that if hemodialysis removes more drug from the plasma than is concomitantly extracted from the tissue stores, independent of any changes in OS' the drug plasma levels would rapidly decline, only to rebound after the dialysis is stopped. Reduction in Os further magnify the rebound phenomena (2) . Neither the mechanisms underlying dialysis induced reductions in Os nor the frequency of its occurrence are known, but a reduction of Os of up to 80% has been observed (3). We have postulated (3) that hemodynam.ic alterations induced by hemodialysis (4) retard Os by perhaps decreasing blood flow to sites of peripheral drug uptake.
By trapping drug in tissue stores, reductions of Os during dialysis decrease the efficacy of drug removal if hemodialysis is begun after the drug has become fully distributed. What is not generally appreciated is the effect on drug removal if hemodialysis is begun before drug distribution is complete. In this instance more drug is trapped in the plasma and is therefore readily accessible to diffuse down the concentration gradient across the artificial kidney. In essence the volume of distribution of the drug is reduced. If Os is reduced by hemodialysis, The International Journal Of Artificial Organs / Vol. 8 no. 2, 1985/ p.p. 69-70 the net effect would be a further reduction in the volume of distribution. As even more drug is trapped in the plasma, drug removal by the artificial kidney is enhanced.
To illustrate these two points I have simulated the percent of the total body burden of digoxin in plasma (central), fast, and slowly equilibrating compartment at various times after bolus administration (Figure 1 ). Digoxin is not dialyzable, but was chosen as an exampple because it requires 6 to 8 hours after intravenous infusion to reach complete tissue distribution. As shown in Figure 1 , initially a very large percentage of the given dose is present in the central compartment, and 'would be readily accessible to the artificial kidney. This rapidly declines as the drug distributes into the major reservoir, the slow compartment, so that by 4 hours 87% of the body burden resides in this compartment. Figure 2 shows the percent of total body burden of drug initially present that is removed during a 3 hours hemodialysis at a clearance of 75 rnl/rnin, begun at various times after bolus drug administration. Shown are the values of percent of initial total body burden removed predicted for the normal OS, and for values of Os reduced 50, 80, and 90%. Regardless of whether or not Os is reduced by hemodialysis, a larger percentage of drug is removed the sooner dialysis is begun and if Os is reduced. One minute after intravenous infusion 23.4% of the body burden is removed. This assumes no change in OS. Were an hour allowed to elapse before starting dialysis, only 9.2% of the body burden present at that time would be removed. This is statistically different (p < 0.05) but not quantitatively different from the 6.2% that would be predicted to be removed after completion of distribution at 8 hours. Even with no change in OS' the percent of the total body burden removed is four-fold greater if dialysis is begun immediately after the intravenous dose compared to 8 hours later after distribution equilibration. If Os is decreased by 50, 80, and 90% the percent removed, starting at one minute, increases to 30, 37.6, and 41.2 percent respectively. By 30 minutes, the respective values are 11%, 12%, 13% and 14%, almost twice of what would have been removed after distribution equilibrium. At two hours, even though (as shown in Figure 1 ) tissue distribution is not complete, the percent of the total body burden removed is identical regardless of what effect hemodialysis may have had upon Os (Figure 2 ). Thereafter the percent removed falls (not shown), as previously reported (2), as Os is reduced.
The purpose of hemodialysis studies is to estimate how much of a drug is removed in the clinical setting. It would seem reasonable then, to mimic the usual clinical situation and allow drug distribution to approch completion. If this is not done, more drug may be removed than would normally be predicted, and excessively large post- dialysis supplemental dosing schedules may be recommended, which could lead to unanticipated toxicity. Intercompartmental clearances and time to complete distribution will vary from drug to drug and from patient to patient. It would therefore seem prudent to design hemodialysis studies after the pharmacokinetics have been determined on a nondialysis day in a given subject. The practice of giving the test drug immediately before (5, 6) or even during hemodialysis should be discouraged. 
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